452 related articles for article (PubMed ID: 11589839)
1. Efficacy of cholesterol levels and ratios in predicting future coronary heart disease in a Chinese population.
Wang TD; Chen WJ; Chien KL; Seh-Yi Su SS; Hsu HC; Chen MF; Liau CS; Lee YT
Am J Cardiol; 2001 Oct; 88(7):737-43. PubMed ID: 11589839
[TBL] [Abstract][Full Text] [Related]
2. Joint effect of high-density lipoprotein cholesterol and low-density lipoprotein cholesterol on the risk of coronary heart disease.
Hu G; Cui Y; Jousilahti P; Sundvall J; Girman CJ; Antikainen R; Laatikainen T; Tuomilehto J
Eur J Prev Cardiol; 2013 Feb; 20(1):89-97. PubMed ID: 22023802
[TBL] [Abstract][Full Text] [Related]
3. Association of high-density lipoprotein cholesterol with coronary heart disease risk across categories of low-density lipoprotein cholesterol: the atherosclerosis risk in communities study.
Muntner P; Lee F; Astor BC
Am J Med Sci; 2011 Mar; 341(3):173-80. PubMed ID: 21042169
[TBL] [Abstract][Full Text] [Related]
4. Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women.
Arsenault BJ; Rana JS; Stroes ES; Després JP; Shah PK; Kastelein JJ; Wareham NJ; Boekholdt SM; Khaw KT
J Am Coll Cardiol; 2009 Dec; 55(1):35-41. PubMed ID: 20117361
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women.
Ingelsson E; Schaefer EJ; Contois JH; McNamara JR; Sullivan L; Keyes MJ; Pencina MJ; Schoonmaker C; Wilson PW; D'Agostino RB; Vasan RS
JAMA; 2007 Aug; 298(7):776-85. PubMed ID: 17699011
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol measures to identify and treat individuals at risk for coronary heart disease.
Natarajan S; Glick H; Criqui M; Horowitz D; Lipsitz SR; Kinosian B
Am J Prev Med; 2003 Jul; 25(1):50-7. PubMed ID: 12818310
[TBL] [Abstract][Full Text] [Related]
7. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
[TBL] [Abstract][Full Text] [Related]
8. Decreased Serum Lipid Levels and Ratios Correlate with Low Prevalence of Coronary Heart Disease in Patients with Parkinson's Disease.
Bao M; Hu R; Chen Y; Wang N; Xue H; He J; Jin J; Kong W; Ke G; Xue Q
Clin Lab; 2018 Sep; 64(9):1413-1419. PubMed ID: 30274018
[TBL] [Abstract][Full Text] [Related]
9. Search for an optimal atherogenic lipid risk profile: from the Framingham Study.
Nam BH; Kannel WB; D'Agostino RB
Am J Cardiol; 2006 Feb; 97(3):372-5. PubMed ID: 16442398
[TBL] [Abstract][Full Text] [Related]
10. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of lipoprotein indices for residual risk of acute myocardial infarction and sudden death in men with low-density lipoprotein cholesterol levels <120 mg/dl.
Tanaka F; Makita S; Onoda T; Tanno K; Ohsawa M; Itai K; Sakata K; Omama S; Yoshida Y; Ogasawara K; Ogawa A; Ishibashi Y; Kuribayashi T; Okayama A; Nakamura M;
Am J Cardiol; 2013 Oct; 112(8):1063-8. PubMed ID: 23831165
[TBL] [Abstract][Full Text] [Related]
12. Contribution of high plasma triglycerides and low high-density lipoprotein cholesterol to residual risk of coronary heart disease after establishment of low-density lipoprotein cholesterol control.
Carey VJ; Bishop L; Laranjo N; Harshfield BJ; Kwiat C; Sacks FM
Am J Cardiol; 2010 Sep; 106(6):757-63. PubMed ID: 20816113
[TBL] [Abstract][Full Text] [Related]
13. Primary Low Level of High-Density Lipoprotein Cholesterol and Risks of Coronary Heart Disease, Cardiovascular Disease, and Death: Results From the Multi-Ethnic Study of Atherosclerosis.
Ahmed HM; Miller M; Nasir K; McEvoy JW; Herrington D; Blumenthal RS; Blaha MJ
Am J Epidemiol; 2016 May; 183(10):875-83. PubMed ID: 27189327
[TBL] [Abstract][Full Text] [Related]
14. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
Bersot TP; Pépin GM; Mahley RW
Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.
Alsheikh-Ali AA; Lin JL; Abourjaily P; Ahearn D; Kuvin JT; Karas RH
Am J Cardiol; 2007 Nov; 100(10):1499-501. PubMed ID: 17996508
[TBL] [Abstract][Full Text] [Related]
16. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Dyslipidemia and Risk of Coronary Heart Disease in 28,318 Adults With Diabetes Mellitus and Low-Density Lipoprotein Cholesterol <100 mg/dl.
Rana JS; Liu JY; Moffet HH; Solomon MD; Go AS; Jaffe MG; Karter AJ
Am J Cardiol; 2015 Dec; 116(11):1700-4. PubMed ID: 26428026
[TBL] [Abstract][Full Text] [Related]
18. Association between non-high-density lipoprotein cholesterol levels and the incidence of coronary heart disease among Japanese: the Circulatory Risk in Communities Study (CIRCS).
Kitamura A; Noda H; Nakamura M; Kiyama M; Okada T; Imano H; Ohira T; Sato S; Yamagishi K; Iso H
J Atheroscler Thromb; 2011; 18(6):454-63. PubMed ID: 21378473
[TBL] [Abstract][Full Text] [Related]
19. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
[TBL] [Abstract][Full Text] [Related]
20. Importance of LDL/HDL cholesterol ratio as a predictor for coronary heart disease events in patients with heterozygous familial hypercholesterolaemia: a 15-year follow-up (1987-2002).
Panagiotakos DB; Pitsavos C; Skoumas J; Chrysohoou C; Toutouza M; Stefanadis CI; Toutouzas PK
Curr Med Res Opin; 2003; 19(2):89-94. PubMed ID: 12755140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
